{"transactions":[{"id":4626672,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-25T12:39:59.000Z","date":"2026-09-23","kind":"purchase","planned":false,"acquired":true,"shares":49036,"price":2.69,"value":131906.84,"ownership":{"direct":true},"balance_after":1046003,"source":{"system":"sec-edgar","filing":"0001493152-26-044250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1499254/000149315226044250/ownership.xml","form_type":"4"}},{"id":4616611,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-14T13:15:10.000Z","date":"2026-09-10","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.73,"value":27300.0,"ownership":{"direct":true},"balance_after":996967,"source":{"system":"sec-edgar","filing":"0001493152-26-042502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1499254/000149315226042502/ownership.xml","form_type":"4"}},{"id":706101,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-20T18:19:30.000Z","date":"2026-07-20","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":3.47,"value":41640.0,"ownership":{"direct":true},"balance_after":986967,"source":{"system":"sec-edgar","filing":"0001493152-26-033949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226033949/ownership.xml","form_type":"4"}},{"id":708553,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-16T09:00:10.000Z","date":"2026-07-15","kind":"purchase","planned":false,"acquired":true,"shares":2797,"price":3.28,"value":9174.16,"ownership":{"direct":true},"balance_after":974967,"source":{"system":"sec-edgar","filing":"0001493152-26-033461","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226033461/ownership.xml","form_type":"4"}},{"id":735274,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T11:21:16.000Z","date":"2026-06-16","kind":"purchase","planned":false,"acquired":true,"shares":2836,"price":2.64,"value":7487.04,"ownership":{"direct":true},"balance_after":972170,"source":{"system":"sec-edgar","filing":"0001493152-26-029030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226029030/ownership.xml","form_type":"4"}},{"id":931474,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2026-01-26T22:01:04.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":370000,"price":0.24,"value":88800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option is awarded as compensation for 2026 Board service.  Option vests in two, equal bi-annual increments on July 22, 2026 and January 22, 2027."}],"balance_after":370000,"derivative":{"exercise_price":0.24,"expiration_date":"2031-01-22","underlying":"Common Stock","underlying_shares":370000},"source":{"system":"sec-edgar","filing":"0001437749-26-002107","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774926002107/rdgdoc.xml","form_type":"4"}},{"id":949151,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2026-01-06T19:44:03.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026."}],"balance_after":25000,"derivative":{"exercise_price":3.18,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-26-000689","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226000689/ownership.xml","form_type":"4"}},{"id":968464,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2025-12-16T08:56:24.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated February 18, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.92,"exercise_date":"2016-02-18","expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-25-027904","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225027904/ownership.xml","form_type":"4"}},{"id":968463,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-16T08:56:24.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":2.92,"value":46720.0,"ownership":{"direct":true},"balance_after":969334,"source":{"system":"sec-edgar","filing":"0001493152-25-027904","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225027904/ownership.xml","form_type":"4"}},{"id":996856,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-18T23:16:13.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":4761905,"price":0.21,"value":1000000.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person purchased 4,761,905 shares of ParkerVision common stock, $0.01 par value, for an aggregate purchase price of $1,000,000 or $0.21 per share, representing the last sale price of ParkerVision's common stock on November 14, 2025.  The transaction closed on November 17, 2025. The offering was made pursuant to an existing shelf registration statement on Form S-3 that was declared effective by the SEC on May 28, 2025 (Registration No. 333-287427). The transaction was reviewed and approved by the disinterested directors of ParkerVision's board of directors in accordance with Section 607.0832 of the Florida Business Corporation Act."}],"balance_after":8578170,"source":{"system":"sec-edgar","filing":"0001437749-25-035628","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774925035628/rdgdoc.xml","form_type":"4"}},{"id":1022592,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Nonqualified Stock Option","published_at":"2025-10-07T21:28:31.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":275000,"price":0.2,"value":55000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Optoin vested in four equal quarterly increments commencing May 1, 2024 and became fully exercisable February 1, 2025."}],"balance_after":0,"derivative":{"exercise_price":0.2,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001437749-25-030658","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774925030658/rdgdoc.xml","form_type":"4"}},{"id":1022591,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Nonqualified Stock Option","published_at":"2025-10-07T21:28:31.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":false,"shares":525000,"price":0.18,"value":94500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vested in equal quarterly installments commencing January 27, 2024."}],"balance_after":75000,"derivative":{"exercise_price":0.18,"expiration_date":"2028-11-18","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001437749-25-030658","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774925030658/rdgdoc.xml","form_type":"4"}},{"id":1022590,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-07T21:28:31.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":true,"shares":275000,"price":0.2,"value":55000.0,"ownership":{"direct":true},"balance_after":3816265,"source":{"system":"sec-edgar","filing":"0001437749-25-030658","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774925030658/rdgdoc.xml","form_type":"4"}},{"id":1022589,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-07T21:28:31.000Z","date":"2025-10-07","kind":"exercise","planned":false,"acquired":true,"shares":525000,"price":0.18,"value":94500.0,"ownership":{"direct":true},"balance_after":3541265,"source":{"system":"sec-edgar","filing":"0001437749-25-030658","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774925030658/rdgdoc.xml","form_type":"4"}},{"id":1077127,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-04T09:00:05.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.08,"value":30800.0,"ownership":{"direct":true},"balance_after":953334,"source":{"system":"sec-edgar","filing":"0001641172-25-022000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225022000/ownership.xml","form_type":"4"}},{"id":1087785,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-15T06:03:41.000Z","date":"2025-07-11","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.14,"value":31400.0,"ownership":{"direct":true},"balance_after":943334,"source":{"system":"sec-edgar","filing":"0001641172-25-019587","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225019587/ownership.xml","form_type":"4"}},{"id":1090930,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common stock","published_at":"2025-07-08T21:11:06.000Z","date":"2025-07-03","kind":"grant","planned":false,"acquired":true,"shares":275000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSU\") awarded as 2025 director compensation.  Each RSU entitles holder to one share of the Company's common stock, $0.01 par value, upon vesting.  RSU vests 50% upon grant and 50% on December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Beneficial ownership, for purposes of this filing, includes 137,500 shares that will be issued upon vesting of the RSU on December 31, 2025."}],"balance_after":3153765,"source":{"system":"sec-edgar","filing":"0001437749-25-022356","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774925022356/rdgdoc.xml","form_type":"4"}},{"id":1154388,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2025-05-09T18:38:54.000Z","date":"2025-05-06","kind":"exercise","planned":false,"acquired":false,"shares":1699844,"price":0.13,"value":220979.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated May 10, 2022, as amended, with a face value of $200,000 and a fixed conversion price of $0.13."}],"balance_after":0,"derivative":{"exercise_price":0.13,"exercise_date":"2022-05-22","expiration_date":"2027-05-22","underlying":"Common Stock","underlying_shares":1699844},"source":{"system":"sec-edgar","filing":"0001641172-25-009406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914139/000164117225009406/ownership.xml","form_type":"4"}},{"id":1154387,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T18:38:54.000Z","date":"2025-05-06","kind":"exercise","planned":false,"acquired":true,"shares":1699844,"price":0.13,"value":220979.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated May 10, 2022, as amended, with a face value of $200,000 and a fixed conversion price of $0.13."}],"balance_after":2878765,"source":{"system":"sec-edgar","filing":"0001641172-25-009406","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000164117225009406/ownership.xml","form_type":"4"}},{"id":1294967,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-27T09:14:35.000Z","date":"2025-01-24","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3,"value":3000.0,"ownership":{"direct":true},"balance_after":933334,"source":{"system":"sec-edgar","filing":"0001493152-25-003733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225003733/ownership.xml","form_type":"4"}},{"id":1294966,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-27T09:14:35.000Z","date":"2025-01-23","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.91,"value":5820.0,"ownership":{"direct":true},"balance_after":932334,"source":{"system":"sec-edgar","filing":"0001493152-25-003733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225003733/ownership.xml","form_type":"4"}},{"id":1297046,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-23T09:11:08.000Z","date":"2025-01-22","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":3.01,"value":6020.0,"ownership":{"direct":true},"balance_after":930334,"source":{"system":"sec-edgar","filing":"0001493152-25-003330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225003330/ownership.xml","form_type":"4"}},{"id":1298352,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-22T09:13:23.000Z","date":"2025-01-21","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":2.59,"value":15540.0,"ownership":{"direct":true},"balance_after":928334,"source":{"system":"sec-edgar","filing":"0001493152-25-003157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225003157/ownership.xml","form_type":"4"}},{"id":1301115,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T14:05:27.000Z","date":"2025-01-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.57,"value":25700.0,"ownership":{"direct":true},"balance_after":922334,"source":{"system":"sec-edgar","filing":"0001493152-25-002717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225002717/ownership.xml","form_type":"4"}},{"id":1309039,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-07T22:46:42.000Z","date":"2025-01-06","kind":"gift","planned":false,"acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1178921,"source":{"system":"sec-edgar","filing":"0001437749-25-000657","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774925000657/rdgdoc.xml","form_type":"4"}},{"id":1317637,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2025-01-03T17:40:36.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2025."}],"balance_after":25000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-25-000317","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225000317/ownership.xml","form_type":"4"}},{"id":1382667,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2024-10-23T11:27:57.000Z","date":"2024-10-22","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated January 2, 2015."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2015-01-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-24-042183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224042183/ownership.xml","form_type":"4"}},{"id":1382666,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-23T11:27:57.000Z","date":"2024-10-22","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":2.575,"value":41200.0,"ownership":{"direct":true},"balance_after":912334,"source":{"system":"sec-edgar","filing":"0001493152-24-042183","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224042183/ownership.xml","form_type":"4"}},{"id":1399748,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Convertible Note","published_at":"2024-09-25T23:13:03.000Z","date":"2024-09-24","kind":"exercise","planned":false,"acquired":false,"shares":405524,"price":0.13,"value":52718.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated January 8, 2020, as amended, with a face value of $50,000 and a fixed conversion price of $0.13."}],"balance_after":0,"derivative":{"exercise_price":0.13,"exercise_date":"2020-01-08","expiration_date":"2025-01-08","underlying":"Common Stock","underlying_shares":405524},"source":{"system":"sec-edgar","filing":"0001437749-24-030006","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924030006/rdgdoc.xml","form_type":"4"}},{"id":1399747,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Convertible Note","published_at":"2024-09-25T23:13:03.000Z","date":"2024-09-24","kind":"exercise","planned":false,"acquired":false,"shares":514740,"price":0.1,"value":51474.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated September 13, 2019, as amended, with a face value of $50,000 and a fixed conversion price of $0.10."}],"balance_after":0,"derivative":{"exercise_price":0.1,"exercise_date":"2019-09-13","expiration_date":"2026-03-15","underlying":"Common Stock","underlying_shares":514740},"source":{"system":"sec-edgar","filing":"0001437749-24-030006","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924030006/rdgdoc.xml","form_type":"4"}},{"id":1399746,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Convertible Note","published_at":"2024-09-25T23:13:03.000Z","date":"2024-09-24","kind":"exercise","planned":false,"acquired":false,"shares":257370,"price":0.1,"value":25737.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated June 19, 2019, as amended, with a face value of $25,000 and a fixed conversion price of $0.10."}],"balance_after":0,"derivative":{"exercise_price":0.1,"exercise_date":"2019-06-19","expiration_date":"2026-03-15","underlying":"Common Stock","underlying_shares":257370},"source":{"system":"sec-edgar","filing":"0001437749-24-030006","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924030006/rdgdoc.xml","form_type":"4"}},{"id":1399745,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-25T23:13:03.000Z","date":"2024-09-24","kind":"exercise","planned":false,"acquired":true,"shares":405524,"price":0.13,"value":52718.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated January 8, 2020, as amended, with a face value of $50,000 and a fixed conversion price of $0.13."}],"balance_after":3178921,"source":{"system":"sec-edgar","filing":"0001437749-24-030006","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924030006/rdgdoc.xml","form_type":"4"}},{"id":1399744,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-25T23:13:03.000Z","date":"2024-09-24","kind":"exercise","planned":false,"acquired":true,"shares":514740,"price":0.1,"value":51474.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated September 13, 2019, as amended, with a face value of $50,000 and a fixed conversion price of $0.10."}],"balance_after":2773397,"source":{"system":"sec-edgar","filing":"0001437749-24-030006","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924030006/rdgdoc.xml","form_type":"4"}},{"id":1399743,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-25T23:13:03.000Z","date":"2024-09-24","kind":"exercise","planned":false,"acquired":true,"shares":257370,"price":0.1,"value":25737.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued upon conversion of, and payment of accrued interest on, a Convertible Note dated June 19, 2019, as amended, with a face value of $25,000 and a fixed conversion price of $0.10."}],"balance_after":2258657,"source":{"system":"sec-edgar","filing":"0001437749-24-030006","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924030006/rdgdoc.xml","form_type":"4"}},{"id":1399742,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common stock","published_at":"2024-09-25T23:13:03.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":8568,"price":0.175,"value":1499.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Interest in kind paid on Convertible Notes dated June 19, 2019 and September 13, 2019."}],"balance_after":2001287,"source":{"system":"sec-edgar","filing":"0001437749-24-030006","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924030006/rdgdoc.xml","form_type":"4"}},{"id":1399741,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-09-25T23:13:03.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":29413,"price":0.17,"value":5000.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Interest in kind paid on Convertible Notes dated January 8, 2020 and May 10, 2022."}],"balance_after":1992719,"source":{"system":"sec-edgar","filing":"0001437749-24-030006","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924030006/rdgdoc.xml","form_type":"4"}},{"id":1444879,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T12:42:57.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":5580,"price":3.23,"value":18023.4,"ownership":{"direct":true},"balance_after":896334,"source":{"system":"sec-edgar","filing":"0001493152-24-029884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029884/ownership.xml","form_type":"4"}},{"id":1444878,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-01T12:42:57.000Z","date":"2024-07-30","kind":"purchase","planned":false,"acquired":true,"shares":21646,"price":3.06,"value":66236.76,"ownership":{"direct":true},"balance_after":890754,"source":{"system":"sec-edgar","filing":"0001493152-24-029884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029884/ownership.xml","form_type":"4"}},{"id":1447731,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-29T06:05:44.000Z","date":"2024-07-26","kind":"purchase","planned":false,"acquired":true,"shares":7700,"price":3.03,"value":23331.0,"ownership":{"direct":true},"balance_after":869108,"source":{"system":"sec-edgar","filing":"0001493152-24-029354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029354/ownership.xml","form_type":"4"}},{"id":1447730,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-29T06:05:44.000Z","date":"2024-07-25","kind":"purchase","planned":false,"acquired":true,"shares":796,"price":2.81,"value":2236.76,"ownership":{"direct":true},"balance_after":861408,"source":{"system":"sec-edgar","filing":"0001493152-24-029354","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224029354/ownership.xml","form_type":"4"}},{"id":1476559,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T09:22:37.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":2.68,"value":10720.0,"ownership":{"direct":true},"balance_after":860612,"source":{"system":"sec-edgar","filing":"0001493152-24-024226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224024226/ownership.xml","form_type":"4"}},{"id":1479983,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T09:56:44.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":405,"price":2.7,"value":1093.5,"ownership":{"direct":true},"balance_after":856612,"source":{"system":"sec-edgar","filing":"0001493152-24-023802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023802/ownership.xml","form_type":"4"}},{"id":1482686,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T11:18:04.000Z","date":"2024-06-11","kind":"purchase","planned":false,"acquired":true,"shares":7102,"price":2.66,"value":18891.32,"ownership":{"direct":true},"balance_after":856207,"source":{"system":"sec-edgar","filing":"0001493152-24-023560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023560/ownership.xml","form_type":"4"}},{"id":1482685,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-12T11:18:04.000Z","date":"2024-06-10","kind":"purchase","planned":false,"acquired":true,"shares":330,"price":2.6,"value":858.0,"ownership":{"direct":true},"balance_after":849105,"source":{"system":"sec-edgar","filing":"0001493152-24-023560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023560/ownership.xml","form_type":"4"}},{"id":1485802,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T10:03:11.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":10738,"price":2.52,"value":27059.76,"ownership":{"direct":true},"balance_after":848775,"source":{"system":"sec-edgar","filing":"0001493152-24-023295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023295/ownership.xml","form_type":"4"}},{"id":1544120,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-10T09:44:51.000Z","date":"2024-04-09","kind":"purchase","planned":false,"acquired":true,"shares":15009,"price":3.28,"value":49229.52,"ownership":{"direct":true},"balance_after":838037,"source":{"system":"sec-edgar","filing":"0001493152-24-014154","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224014154/ownership.xml","form_type":"4"}},{"id":1650168,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-12T22:36:55.000Z","date":"2023-12-19","kind":"other","planned":false,"acquired":true,"shares":9375,"price":0.16,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reporting Person acquired shares of common stock as quarterly interest payments in-kind on a convertible note dated June 19, 2019 with a principal balance of $25,000 and a convertible note dated September 13, 2019 with a principal balance of $50,000."}],"balance_after":1963306,"source":{"system":"sec-edgar","filing":"0001437749-24-003790","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924003790/rdgdoc.xml","form_type":"5"}},{"id":1650167,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-12T22:36:55.000Z","date":"2023-10-15","kind":"other","planned":false,"acquired":true,"shares":54947,"price":0.091,"value":5000.177,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reporting Person acquired shares of common stock as quarterly interest-in-kind payments on a convertible note dated January 8, 2020 with a principal balance of $50,000 and a convertible note dated May 10, 2022 with a principal balance of $200,000."}],"balance_after":1953931,"source":{"system":"sec-edgar","filing":"0001437749-24-003790","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924003790/rdgdoc.xml","form_type":"5"}},{"id":1650166,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-12T22:36:55.000Z","date":"2023-09-19","kind":"other","planned":false,"acquired":true,"shares":15000,"price":0.1,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reporting Person acquired shares of common stock as quarterly interest payments in-kind on a convertible note dated June 19, 2019 with a principal balance of $25,000 and a convertible note dated September 13, 2019 with a principal balance of $50,000."}],"balance_after":1898984,"source":{"system":"sec-edgar","filing":"0001437749-24-003790","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924003790/rdgdoc.xml","form_type":"5"}},{"id":1650165,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-12T22:36:55.000Z","date":"2023-09-10","kind":"other","planned":false,"acquired":true,"shares":21053,"price":0.095,"value":2000.035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person acquired shares of common stock as quarterly interest payments in-kind on a convertible note dated September 2018 with a principal balance of $100,000."}],"balance_after":1883984,"source":{"system":"sec-edgar","filing":"0001437749-24-003790","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924003790/rdgdoc.xml","form_type":"5"}},{"id":1650164,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-12T22:36:55.000Z","date":"2023-07-15","kind":"other","planned":false,"acquired":true,"shares":54230,"price":0.092,"value":4989.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reporting Person acquired shares of common stock as quarterly interest-in-kind payments on a convertible note dated January 8, 2020 with a principal balance of $50,000 and a convertible note dated May 10, 2022 with a principal balance of $200,000."}],"balance_after":1862931,"source":{"system":"sec-edgar","filing":"0001437749-24-003790","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924003790/rdgdoc.xml","form_type":"5"}},{"id":1659725,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-05T22:04:13.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0.2,"value":55000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option was awarded as 2024 compensation for board and committee service and is exercisable in four equal quarterly increments beginning 5/1/2024."}],"balance_after":275000,"derivative":{"exercise_price":0.2,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001437749-24-003135","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774924003135/rdgdoc.xml","form_type":"4"}},{"id":1679556,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-16T19:05:16.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2024."}],"balance_after":25000,"derivative":{"exercise_price":4.39,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-002526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224002526/ownership.xml","form_type":"4"}},{"id":1731791,"issuer":{"id":7682,"kind":"organization","name":"PARKERVISION INC"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2023-11-22T21:06:18.000Z","date":"2023-11-18","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0.177,"value":106200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in eight equal quarterly increments beginning February 18, 2024."}],"balance_after":600000,"derivative":{"exercise_price":0.177,"expiration_date":"2028-11-18","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001437749-23-032893","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914139/000143774923032893/rdgdoc.xml","form_type":"4"}},{"id":1762250,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2023-10-11T10:35:57.000Z","date":"2023-10-10","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated January 2, 2014."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2014-01-02","expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-23-036871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223036871/ownership.xml","form_type":"4"}},{"id":1762249,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-11T10:35:57.000Z","date":"2023-10-10","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":2.575,"value":41200.0,"ownership":{"direct":true},"balance_after":823028,"source":{"system":"sec-edgar","filing":"0001493152-23-036871","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223036871/ownership.xml","form_type":"4"}},{"id":1821076,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-31T18:36:13.000Z","date":"2023-07-27","kind":"exercise","planned":false,"acquired":false,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated November 8, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2013-11-08","expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001493152-23-026127","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026127/ownership.xml","form_type":"4"}},{"id":1821075,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-31T18:36:13.000Z","date":"2023-07-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":87042,"price":3.55,"value":308999.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to cover the exercise price of the stock options."}],"balance_after":807028,"source":{"system":"sec-edgar","filing":"0001493152-23-026127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026127/ownership.xml","form_type":"4"}},{"id":1821074,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-31T18:36:13.000Z","date":"2023-07-27","kind":"exercise","planned":false,"acquired":true,"shares":120000,"price":2.575,"value":309000.0,"ownership":{"direct":true},"balance_after":894070,"source":{"system":"sec-edgar","filing":"0001493152-23-026127","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026127/ownership.xml","form_type":"4"}},{"id":2071075,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-04T20:52:33.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2023."}],"balance_after":25000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-000421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223000421/ownership.xml","form_type":"4"}},{"id":2149090,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2022-09-30T10:34:25.000Z","date":"2022-09-29","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated February 15, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2013-02-15","expiration_date":"2023-02-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-027222","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222027222/ownership.xml","form_type":"4"}},{"id":2149089,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-30T10:34:25.000Z","date":"2022-09-29","kind":"exercise","acquired":true,"shares":40000,"price":2.575,"value":103000.0,"ownership":{"direct":true},"balance_after":774070,"source":{"system":"sec-edgar","filing":"0001493152-22-027222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222027222/ownership.xml","form_type":"4"}},{"id":2157992,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T17:08:23.000Z","date":"2022-09-14","kind":"gift","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of two separate bona fide gift transactions exempt under Rule 16b-5. No shares were sold in this transaction. Mr. Titterton transferred the shares to his children for estate planning purposes."}],"balance_after":734070,"source":{"system":"sec-edgar","filing":"0001493152-22-026101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222026101/ownership.xml","form_type":"4"}},{"id":2220643,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2022-06-28T10:21:32.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated March 28, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2013-03-28","expiration_date":"2022-12-31","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001493152-22-017926","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222017926/ownership.xml","form_type":"4"}},{"id":2220642,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2022-06-28T10:21:32.000Z","date":"2022-06-24","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, pursuant to a stock option grant dated September 19, 2012."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2012-09-19","expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-22-017926","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222017926/ownership.xml","form_type":"4"}},{"id":2220641,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T10:21:32.000Z","date":"2022-06-24","kind":"exercise","acquired":true,"shares":16000,"price":2.575,"value":41200.0,"ownership":{"direct":true},"balance_after":1034070,"source":{"system":"sec-edgar","filing":"0001493152-22-017926","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222017926/ownership.xml","form_type":"4"}},{"id":2220640,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T10:21:32.000Z","date":"2022-06-24","kind":"exercise","acquired":true,"shares":30000,"price":2.575,"value":77250.0,"ownership":{"direct":true},"balance_after":1018070,"source":{"system":"sec-edgar","filing":"0001493152-22-017926","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222017926/ownership.xml","form_type":"4"}},{"id":2290038,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-27T10:01:02.000Z","date":"2022-04-26","kind":"purchase","acquired":true,"shares":10000,"price":2.79,"value":27900.0,"ownership":{"direct":true},"balance_after":988070,"source":{"system":"sec-edgar","filing":"0001493152-22-011291","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222011291/ownership.xml","form_type":"4"}},{"id":2338856,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-11T16:15:40.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning March 31, 2022."}],"balance_after":100000,"derivative":{"exercise_price":2.74,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-006627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222006627/ownership.xml","form_type":"4"}},{"id":2436341,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-13T10:23:29.000Z","date":"2022-01-12","kind":"purchase","acquired":true,"shares":5000,"price":3.28,"value":16400.0,"ownership":{"direct":true},"balance_after":978070,"source":{"system":"sec-edgar","filing":"0001493152-22-001112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222001112/ownership.xml","form_type":"4"}},{"id":2437246,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-12T09:54:27.000Z","date":"2022-01-11","kind":"purchase","acquired":true,"shares":2000,"price":3.2,"value":6400.0,"ownership":{"direct":true},"balance_after":973070,"source":{"system":"sec-edgar","filing":"0001493152-22-001018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222001018/ownership.xml","form_type":"4"}},{"id":2438418,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-11T09:21:56.000Z","date":"2022-01-10","kind":"purchase","acquired":true,"shares":6000,"price":3.08,"value":18480.0,"ownership":{"direct":true},"balance_after":971070,"source":{"system":"sec-edgar","filing":"0001493152-22-000899","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222000899/ownership.xml","form_type":"4"}},{"id":2439450,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-10T09:36:32.000Z","date":"2022-01-07","kind":"purchase","acquired":true,"shares":11000,"price":3.08,"value":33880.0,"ownership":{"direct":true},"balance_after":965070,"source":{"system":"sec-edgar","filing":"0001493152-22-000767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222000767/ownership.xml","form_type":"4"}},{"id":2531331,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-01T13:32:23.000Z","date":"2021-10-29","kind":"purchase","acquired":true,"shares":18244,"price":4.76,"value":86841.44,"ownership":{"direct":true},"balance_after":954070,"source":{"system":"sec-edgar","filing":"0001493152-21-026841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221026841/ownership.xml","form_type":"4"}},{"id":2623490,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-28T09:00:16.000Z","date":"2021-07-26","kind":"purchase","acquired":true,"shares":30000,"price":4.21,"value":126300.0,"ownership":{"direct":true},"balance_after":935826,"source":{"system":"sec-edgar","filing":"0001493152-21-017937","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221017937/ownership.xml","form_type":"4"}},{"id":2631269,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-19T12:39:47.000Z","date":"2021-07-16","kind":"purchase","acquired":true,"shares":10000,"price":4.07,"value":40700.0,"ownership":{"direct":true},"balance_after":905826,"source":{"system":"sec-edgar","filing":"0001493152-21-017157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221017157/ownership.xml","form_type":"4"}},{"id":2631268,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-19T12:39:47.000Z","date":"2021-07-15","kind":"purchase","acquired":true,"shares":2200,"price":3.65,"value":8030.0,"ownership":{"direct":true},"balance_after":895826,"source":{"system":"sec-edgar","filing":"0001493152-21-017157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221017157/ownership.xml","form_type":"4"}},{"id":2633594,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-15T11:19:36.000Z","date":"2021-07-14","kind":"purchase","acquired":true,"shares":23300,"price":3.72,"value":86676.0,"ownership":{"direct":true},"balance_after":893626,"source":{"system":"sec-edgar","filing":"0001493152-21-016912","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221016912/ownership.xml","form_type":"4"}},{"id":2687918,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-02T17:00:34.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning June 30, 2021."}],"balance_after":200000,"derivative":{"exercise_price":4.02,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-21-013456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221013456/ownership.xml","form_type":"4"}},{"id":2687917,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-02T17:00:34.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning June 30, 2021."}],"balance_after":30000,"derivative":{"exercise_price":4.02,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-21-013456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221013456/ownership.xml","form_type":"4"}},{"id":2744428,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-20T10:32:26.000Z","date":"2021-04-19","kind":"purchase","acquired":true,"shares":5000,"price":3.99,"value":19950.0,"ownership":{"direct":true},"balance_after":870326,"source":{"system":"sec-edgar","filing":"0001493152-21-009211","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221009211/ownership.xml","form_type":"4"}},{"id":2771320,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-26T11:06:25.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":45000,"price":4.84,"value":217800.0,"ownership":{"direct":true},"balance_after":865326,"source":{"system":"sec-edgar","filing":"0001493152-21-006895","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221006895/ownership.xml","form_type":"4"}},{"id":2878269,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T16:44:10.000Z","date":"2021-02-03","kind":"gift","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of two separate bona fide gift transactions exempt under Rule 16b-5."}],"balance_after":820326,"source":{"system":"sec-edgar","filing":"0001493152-21-002803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221002803/ownership.xml","form_type":"4"}},{"id":3032775,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-14T09:29:32.000Z","date":"2020-09-11","kind":"purchase","acquired":true,"shares":40000,"price":2.08,"value":83200.0,"ownership":{"direct":true},"balance_after":1020326,"source":{"system":"sec-edgar","filing":"0001493152-20-017705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315220017705/ownership.xml","form_type":"4"}},{"id":3056605,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-08-17T16:45:31.000Z","date":"2020-08-13","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning August 31, 2020."}],"balance_after":30000,"derivative":{"exercise_price":2.68,"expiration_date":"2030-08-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001513162-20-000175","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000175/primary_doc.xml","form_type":"4"}},{"id":3108020,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-17T10:30:39.000Z","date":"2020-06-16","kind":"purchase","acquired":true,"shares":24500,"price":2.27,"value":55615.0,"ownership":{"direct":true},"balance_after":980326,"source":{"system":"sec-edgar","filing":"0001513162-20-000127","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000127/primary_doc.xml","form_type":"4"}},{"id":3109829,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T11:43:30.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":31083,"price":2.27,"value":70558.41,"ownership":{"direct":true},"balance_after":955826,"source":{"system":"sec-edgar","filing":"0001513162-20-000124","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000124/primary_doc.xml","form_type":"4"}},{"id":3207596,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-17T15:46:15.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":5799,"price":2.12,"value":12293.88,"ownership":{"direct":true},"balance_after":924743,"source":{"system":"sec-edgar","filing":"0001513162-20-000054","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000054/primary_doc.xml","form_type":"4"}},{"id":3310277,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-16T11:22:51.000Z","date":"2020-01-15","kind":"purchase","acquired":true,"shares":5000,"price":3.32,"value":16600.0,"ownership":{"direct":true},"balance_after":918944,"source":{"system":"sec-edgar","filing":"0001513162-20-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000019/primary_doc.xml","form_type":"4"}},{"id":3311246,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-15T10:57:35.000Z","date":"2020-01-14","kind":"purchase","acquired":true,"shares":7400,"price":3.22,"value":23828.0,"ownership":{"direct":true},"balance_after":913944,"source":{"system":"sec-edgar","filing":"0001513162-20-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000018/primary_doc.xml","form_type":"4"}},{"id":3388952,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-10-24T20:17:39.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in twelve (12) equal monthly installments beginning November 30, 2019."}],"balance_after":45000,"derivative":{"exercise_price":3.87,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001513162-19-000227","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000227/primary_doc.xml","form_type":"4"}},{"id":3409514,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option was originally granted on February 18, 2016 and vested in four (4) equal installments on each of March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016."}],"balance_after":16000,"derivative":{"exercise_price":2.92,"expiration_date":"2026-01-14","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}},{"id":3409513,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option was originally granted on February 18, 2016 and vested in four (4) equal installments on each of March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2026-01-14","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}},{"id":3409512,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option was originally granted on January 2, 2015 and vested in four (4) equal installments on each of March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015."}],"balance_after":16000,"derivative":{"exercise_price":2.575,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}},{"id":3409511,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option was originally granted on January 2, 2015 and vested in four (4) equal installments on each of March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}},{"id":3409510,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option was originally granted on January 2, 2014 and vested in four (4) equal installments on each of March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014."}],"balance_after":16000,"derivative":{"exercise_price":2.575,"expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}},{"id":3409509,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option was originally granted on January 2, 2014 and vested in four (4) equal installments on each of March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}},{"id":3409508,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013."}],"balance_after":120000,"derivative":{"exercise_price":2.575,"expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}},{"id":3409507,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":120000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}},{"id":3409506,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":29608,"kind":"person","name":"Titterton Lewis H jr","position":1,"cik":"0001499254","reported_name":"Titterton Lewis H jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option","published_at":"2019-09-20T18:48:24.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on July 17, 2017 and vests and become exercisable in two equal installments on each September 30, 2017 and December 31, 2017."}],"balance_after":6000,"derivative":{"exercise_price":0.82,"expiration_date":"2027-07-17","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001513162-19-000214","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/primary_doc.xml","form_type":"4"}}],"next_cursor":"2019-09-20T18:48:24.000000Z,3409506"}